These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26436115)

  • 1. Hepatitis B virus infection: An insight into infection outcomes and recent treatment options.
    Noordeen F
    Virusdisease; 2015 Jun; 26(1-2):1-8. PubMed ID: 26436115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance.
    Yang HC; Kao JH
    Emerg Microbes Infect; 2014 Sep; 3(9):e64. PubMed ID: 26038757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New horizon for radical cure of chronic hepatitis B virus infection.
    Tajiri K; Shimizu Y
    World J Hepatol; 2016 Jul; 8(21):863-73. PubMed ID: 27478536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential.
    Dandri M; Petersen J
    Clin Infect Dis; 2016 Jun; 62 Suppl 4(Suppl 4):S281-8. PubMed ID: 27190317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic strategies for a functional cure of chronic hepatitis B virus infection.
    Chang J; Guo F; Zhao X; Guo JT
    Acta Pharm Sin B; 2014 Aug; 4(4):248-57. PubMed ID: 26579392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.
    Xia Y; Stadler D; Lucifora J; Reisinger F; Webb D; Hösel M; Michler T; Wisskirchen K; Cheng X; Zhang K; Chou WM; Wettengel JM; Malo A; Bohne F; Hoffmann D; Eyer F; Thimme R; Falk CS; Thasler WE; Heikenwalder M; Protzer U
    Gastroenterology; 2016 Jan; 150(1):194-205. PubMed ID: 26416327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latest developments in the treatment of hepatitis B.
    Dandri M; Petersen J
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
    Sheraz M; Cheng J; Tang L; Chang J; Guo JT
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting Hepatitis B Virus: Challenges of Curative Therapies.
    Hu J; Protzer U; Siddiqui A
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31375584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication.
    Dong C; Qu L; Wang H; Wei L; Dong Y; Xiong S
    Antiviral Res; 2015 Jun; 118():110-7. PubMed ID: 25843425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of the study of hepatitis B virus covalently closed circular DNA.
    Kumar R; Pérez-Del-Pulgar S; Testoni B; Lebossé F; Zoulim F
    Liver Int; 2016 Jan; 36 Suppl 1():72-7. PubMed ID: 26725901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of cccDNA in HBV Maintenance.
    Allweiss L; Dandri M
    Viruses; 2017 Jun; 9(6):. PubMed ID: 28635668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo.
    Allweiss L; Volz T; Giersch K; Kah J; Raffa G; Petersen J; Lohse AW; Beninati C; Pollicino T; Urban S; Lütgehetmann M; Dandri M
    Gut; 2018 Mar; 67(3):542-552. PubMed ID: 28428345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes.
    Bohne F; Chmielewski M; Ebert G; Wiegmann K; Kürschner T; Schulze A; Urban S; Krönke M; Abken H; Protzer U
    Gastroenterology; 2008 Jan; 134(1):239-47. PubMed ID: 18166356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B Virus Covalently Closed Circular DNA Formation in Immortalized Mouse Hepatocytes Associated with Nucleocapsid Destabilization.
    Cui X; Guo JT; Hu J
    J Virol; 2015 Sep; 89(17):9021-8. PubMed ID: 26085156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients.
    Boyd A; Lacombe K; Lavocat F; Maylin S; Miailhes P; Lascoux-Combe C; Delaugerre C; Girard PM; Zoulim F
    J Hepatol; 2016 Oct; 65(4):683-691. PubMed ID: 27210429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?
    Alonso S; Guerra AR; Carreira L; Ferrer JÁ; Gutiérrez ML; Fernandez-Rodriguez CM
    BMC Gastroenterol; 2017 Dec; 17(1):168. PubMed ID: 29268704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating the innate immune response to counter chronic hepatitis B virus infection.
    Lamb C; Arbuthnot P
    Expert Opin Biol Ther; 2016 Dec; 16(12):1517-1527. PubMed ID: 27603796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B Virus Immunopathology, Model Systems, and Current Therapies.
    Sandhu P; Haque M; Humphries-Bickley T; Ravi S; Song J
    Front Immunol; 2017; 8():436. PubMed ID: 28450868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B Virus DNA Integration Occurs Early in the Viral Life Cycle in an
    Tu T; Budzinska MA; Vondran FWR; Shackel NA; Urban S
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29437961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.